Sign In
Buy TMCI
$3.40
-0.0700 (-2.02%)
At Close: Jun 03, 2026
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Treace Medical Concepts, Inc. (NASDAQ: TMCI). The investigation focuses on
Treace Medical Concepts Q1 Earnings Call Highlights
12:08am, Saturday, 09'th May 2026
Treace Medical Concepts NASDAQ: TMCI reaffirmed its full-year 2026 revenue outlook after reporting a first-quarter revenue decline, as management said new product adoption is helping drive procedure v
Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript
11:01am, Friday, 08'th May 2026
Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript
Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates
09:26am, Friday, 08'th May 2026
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.25 per share a year ago.
Treace Medical Concepts Reports First Quarter 2026 Financial Results
07:05am, Friday, 08'th May 2026
PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical
Treace to Report First Quarter 2026 Financial Results on May 8, 2026
07:05am, Friday, 24'th Apr 2026
PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System
09:04am, Tuesday, 07'th Apr 2026
New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens Treace's comprehensive suite of technologies for its growing customer base New portfolio addition tap
Treace Medical Concepts (NASDAQ:TMCI) and PAVmed (NASDAQ:PAVM) Head-To-Head Survey
01:01am, Tuesday, 07'th Apr 2026
PAVmed (NASDAQ: PAVM - Get Free Report) and Treace Medical Concepts (NASDAQ: TMCI - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two b
Treace Medical Concepts Q4 Earnings Call Highlights
05:04am, Monday, 02'nd Mar 2026
Treace Medical Concepts (NASDAQ: TMCI) management told investors it is entering what it called a "transformational phase," expanding beyond its historical Lapiplasty focus to become a broader "compreh
Treace Medical Concepts, Inc. (TMCI) Q4 2025 Earnings Call Transcript
02:57pm, Friday, 27'th Feb 2026
Treace Medical Concepts, Inc. (TMCI) Q4 2025 Earnings Call Transcript
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results
07:05am, Friday, 27'th Feb 2026
PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
07:05am, Tuesday, 24'th Feb 2026
PONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
First Eagle Small Cap Opportunity Fund Q4 2025 Portfolio Review
02:27pm, Thursday, 19'th Feb 2026
First Eagle Small Cap Opportunity Fund A Shares (without sales charge*) posted a return of 1.71% in fourth quarter 2025. Small Cap Opportunity Fund A Shares (without sales charge*) posted a return of
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
05:13pm, Thursday, 12'th Feb 2026
PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
301,100 Shares in Treace Medical Concepts, Inc. $TMCI Acquired by Acuitas Investments LLC
03:03am, Friday, 30'th Jan 2026
Acuitas Investments LLC purchased a new position in Treace Medical Concepts, Inc. (NASDAQ: TMCI) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Comm
